TNXP
Tonix Pharmaceuticals Holding Corp
9.70$
-5.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 22.5% | 30.9% | 22.2% | 36.0% | 53.2% | 73.1% | 77.6% | 76.6% | 82.4% | 82.6% | 80.3% | 80.1% | |
| 5.0% | 16.2% | 5.2% | 5.9% | 29.7% | 60.6% | 68.3% | 66.9% | 75.3% | 74.9% | 71.9% | 69.4% | |
| 5.0% | – | 5.2% | 5.9% | 29.7% | 60.6% | 68.3% | 66.9% | 75.3% | 74.9% | 71.9% | 69.4% | |
| 1.1% | 0.0% | 3.4% | 4.7% | 4.2% | 4.9% | 2.5% | 4.2% | 1.4% | 3.5% | 3.4% | 4.6% | |
| 9.6% | 9.2% | 9.1% | 13.5% | 8.3% | 5.2% | 4.2% | 3.2% | 2.3% | 2.2% | 1.4% | 2.2% | |
| 0.7% | 0.6% | 0.7% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 7.2% | 6.3% | 7.0% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 13.2% | 31.7% | 20.1% | 40.1% | 21.9% | 14.3% | 6.5% | 10.3% | 8.4% | 11.6% | 11.9% | 12.5% | |
| 12.7% | 12.2% | 15.1% | 31.4% | 16.0% | 11.2% | 6.3% | 10.2% | 8.3% | 11.1% | 11.5% | 12.1% | |
| 0.3% | – | 2.3% | 4.8% | 3.3% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.1% | |
| 5.6% | 2.4% | 4.9% | 14.8% | 4.1% | 2.8% | 2.2% | 4.2% | 3.4% | 2.9% | 3.7% | 3.6% | |
| – | 4.2% | 4.5% | 8.1% | 5.4% | 2.9% | – | – | – | – | – | – | |
| 86.8% | 68.3% | 79.9% | 59.9% | 78.1% | 85.7% | 93.5% | 89.7% | 91.6% | 88.4% | 88.1% | 87.5% | |
| -411.6% | -388.9% | -454.8% | -987.6% | -746.0% | -448.6% | -387.6% | -414.1% | -320.0% | -308.4% | -347.0% | -368.2% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 1.4% | 3.1% | 3.9% | 3.5% | 3.1% | 5.3% | 6.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.